Welcome to New Orleans!

An Investment Reminder

February 10, 2025

Hey there, lovely readers! If you’re an investor or thinking about diving into the world of securities, we’ve got a little reminder for you. The folks at Kahn Swick & Foti, LLC (“KSF”) and their partner, former Louisiana Attorney General Charles C. Foti, Jr., want to make sure you’re in the loop regarding a securities class action lawsuit. You have until March 14, 2025, to file lead plaintiff applications in the case against Pacira BioSciences, Inc. (NasdaqGS:PCRX).

The lawsuit focuses on securities purchased between August 2, 2023, and August 8, 2024, during what is known as the “Class Period.” So, if you were involved in any transactions with the Company during that time, you may want to pay close attention!

Now, let’s break down what this all means for you and the wider world:

Effect on You: As an individual investor, being aware of such lawsuits can be beneficial in ensuring your financial interests are protected. By taking action and filing a lead plaintiff application, you may have the opportunity to seek redress if you suffered losses due to any alleged misconduct by the Company.

Effect on the World: Securities class action lawsuits can have broader implications for the financial markets and corporate governance. They often serve as a mechanism for holding companies accountable for their actions and promoting transparency and fairness in the business world.

In Conclusion

So, there you have it! Remember, March 14, 2025, is the deadline to file lead plaintiff applications in the securities class action lawsuit against Pacira BioSciences, Inc. Stay informed, stay vigilant, and always make sure your investments are in good hands. Happy investing!